Safety Profile and Efficacy of Ivabradine in Heart Failure Due to Chagas Heart Disease: A Post Hoc Analysis of the SHIFT Trial

ESC heart failure - France
doi 10.1002/ehf2.12240
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-Shift Study ―

Circulation Journal
MedicineCardiovascular MedicineCardiology
2019English

Reply: Sacubitril/Valsartan for Chagas' Heart Disease Heart Failure?

ESC heart failure
Cardiovascular MedicineCardiology
2018English

Estimating Clinical Morbidity Due to Ischemic Heart Disease and Congestive Heart Failure: The Future Rise of Heart Failure.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1994English

Treatment of Congestive Heart Failure Due to Rheumatic Valvular Heart Disease

Japanese Circulation Journal
1973English

Ivabradine: Current and Future Treatment of Heart Failure

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2017English

Efficacy and Safety of Trimetazidine (Сarmetadin) in the Comprehensive Treatment of Patients With Ischemic Heart Disease and Chronic Heart Failure

HYPERTENSION
2018English

Chagas Heart Disease

Cardiovascular Medicine
2018English

Efficacy and Safety of Goreisan for Chronic Heart Failure Patients With Chronic Kidney Disease

Kampo Medicine
2019English

Ivabradine Added to Guidelines-Based Therapy in Systolic Heart Failure Patients

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy